Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review
Few papers focus their attention on VZV vaccination effectiveness among people living with HIV (PLWH). Flanking the live attenuated vaccine (VZL) available, a newly recombinant vaccine (RZV) was recently introduced and approved for HZ prevention among adults. PLWH represents a population on which a...
Saved in:
| Main Authors: | Valentina Carta, Lucia Mangeri, Giorgio Tiecco, Emanuele Focà, Eugenia Quiros-Roldan, Maria Antonia De Francesco |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2341456 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Varicella Zoster Virus Infection and Pregnancy: An Optimal Management Approach
by: Ana Ion, et al.
Published: (2025-02-01) -
Atypical polyneuropathy caused by varicella Zoster virus: Involvement of vestibulocochlear, glossopharyngeal and vagus nerves
by: Mafalda Silva Ferreira, et al.
Published: (2019-08-01) -
Research Progress on Varicella-Zoster Virus Vaccines
by: Hongjing Liu, et al.
Published: (2025-07-01) -
Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus
by: Giacomo Casabona, et al.
Published: (2025-12-01) -
Evaluating the Immunogenicity, Efficacy, and Effectiveness of Recombinant Zoster Vaccine for Global Public Health Policy
by: Lucy R. Williams, et al.
Published: (2025-02-01)